Kala azar, also known as Visceral Leishmaniasis (VL), is a neglected tropical disease caused by the parasite Leishmania donovani. It is prevalent in South Asia, East Africa, and South America, primarily affecting impoverished and marginalized communities in remote and rural areas with limited healthcare access.
Historically, Kala azar has been recognized in India and other endemic regions for centuries. Early accounts from the 19th century describe symptoms resembling visceral leishmaniasis. However, it was not until 1903 that the causative parasite, Leishmania donovani, was identified by Sir William Leishman, a British bacteriologist working in India. The disease acquired its name "Kala azar" from Hindustani, meaning "black fever," in reference to the grayish discoloration of the patient's skin.
Kala azar is endemic in approximately 65 countries worldwide, with India, Bangladesh, Nepal, Sudan, South Sudan, and Brazil accounting for the majority of cases. These countries represent around 90% of reported global cases. However, there is a potential for outbreak and the disease can affect other regions under specific circumstances.
The primary mode of transmission for Kala azar is through the bite of infected female sand flies belonging to the Phlebotomus genus (such as Phlebotomus argentipes and Phlebotomus orientalis) in the Indian subcontinent and the Lutzomyia genus (such as Lutzomyia longipalpis) in the Americas. These sand flies acquire the parasite by biting an infected human or animal reservoir.
Kala azar affects both children and adults, although children under 15 are most vulnerable to severe forms of the disease. Poverty, malnutrition, and weakened immune systems contribute to increased susceptibility in endemic areas. Additionally, conditions such as HIV/AIDS, tuberculosis, and malaria increase the risk of developing or exacerbating Kala azar.
According to the World Health Organization (WHO), there are an estimated 50,000 to 90,000 new cases of Kala azar globally each year. However, due to underreporting and limited surveillance systems, the actual number of cases is likely higher. The estimated annual death toll ranges from 20,000 to 40,000 people. India alone reportedly accounts for approximately 70% of the global burden of Kala azar.
Several factors contribute to the transmission of Kala azar, including proximity to sand fly breeding sites, poor housing conditions, limited access to effective vector control measures, migration of infected individuals, and inadequate availability and accessibility to diagnosis and treatment services.
The impact of Kala azar varies among regions and populations. Sudan and South Sudan have the highest burden in Africa, accounting for over 50% of global cases. In India, the disease is endemic in the eastern states, particularly Bihar, Jharkhand, and West Bengal. Nepal and Bangladesh also have significant prevalence rates. Brazil is the most affected country in South America. Within these regions, marginalized and vulnerable populations such as migrant workers, refugees, and displaced persons bear a disproportionate burden of the disease.
Prevalence rates of Kala azar can vary within countries and even within different regions of the same country. Factors such as variations in sand fly distribution and behavior, local ecological conditions, and access to healthcare services contribute to these variations. Socioeconomic disparities, including poverty and limited healthcare infrastructure, further amplify the impact of Kala azar on vulnerable populations.
In conclusion, Kala azar is a neglected tropical disease that significantly affects communities in South Asia, East Africa, and South America. Transmission occurs primarily through sand fly bites, and it disproportionately impacts marginalized and vulnerable populations. To reduce the burden of Kala azar globally, improved surveillance, effective vector control measures, increased access to diagnosis and treatment, and enhanced public health interventions are crucial.

Download Data(下载数据)

Seasonal Patterns of Kala Azar in Mainland China:
The data provided indicates a distinct seasonal pattern in the occurrence of Kala azar cases in mainland China. Specifically, there is a higher number of cases during the summer and autumn months (June to November), while the lowest number of cases is observed during the winter and spring months (December to May). This finding suggests a potential association between Kala azar incidence and environmental factors like temperature and rainfall.
Peak and Trough Periods:
In mainland China, the peak period for Kala azar cases occurs in October and November, during which the number of cases reaches its highest point. Subsequently, there is a gradual decline in cases during the winter and spring months, resulting in a trough in January, February, and March.
Overall Trends:
Overall, there has been a decreasing trend in the number of Kala azar cases over the years. Notably, from 2010 to 2015, there was a slight increase in cases, followed by a sharp decline from 2015 to 2019. Following 2019, there has been a minor fluctuation in case numbers, with no significant upward or downward trend observed.
The seasonal pattern of Kala azar cases in mainland China implies a potential influence of varying environmental factors throughout the year. The peak in cases during the summer and autumn could potentially be linked to factors such as heightened sandfly activity, which serves as the vector for Kala azar transmission.
The decreasing trend observed in the overall number of cases over the years is encouraging and indicates the successful implementation of control and prevention measures in mainland China. Nonetheless, it is crucial to maintain vigilant monitoring and efficiently functioning surveillance systems to prevent any potential resurgence of the disease.
Further analysis and investigation into the specific environmental factors influencing the seasonal patterns of Kala azar could provide valuable insights for targeted interventions and control strategies. Additionally, a separate examination of cases and deaths would help elucidate the dynamics between disease incidence and mortality.